We are live on
!
Find out more
DC
Defender Capital Portfolio holdings
AUM
$308M
1-Year Est. Return
4.52%
This Fund
S&P 500
This Quarter
Est. Return
-5.81%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$10.9M
(-8.8%)
Cap. Flow
-$3M
Cap. Flow
% of AUM
-2.66%
Top 10 Holdings %
Top 10 Hldgs %
96.1%
Holding
18
New
2
Increased
2
Reduced
13
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.8M |
| 2 |
Microsoft
MSFT
|
+$209K |
| 3 |
Fortive
FTV
|
+$21.8K |
| 4 |
Apple
AAPL
|
+$3.14K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$2.24M |
| 2 |
Danaher
DHR
|
+$1.28M |
| 3 |
Monster Beverage
MNST
|
+$617K |
| 4 |
Enovis
ENOV
|
+$543K |
| 5 |
STAAR Surgical
STAA
|
+$535K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 41.73% |
| 2 | Financials | 22.58% |
| 3 | Consumer Staples | 14.38% |
| 4 | Technology | 13.18% |
| 5 | Consumer Discretionary | 3.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Berkshire Hathaway Class B
BRK.B
$1.06T
| $25.5M | 22.58% |
122,417
-10,885
| -8% | -$2.24M |
|
|
2
Danaher
DHR
$142B
| $20.2M | 17.88% |
157,769
-10,208
| -6% | -$1.28M |
|
|
3
Monster Beverage
MNST
$93.4B
| $16.2M | 14.38% |
558,730
-20,360
| -4% | -$617K |
|
|
4
STAAR Surgical
STAA
$1.19B
| $15.1M | 13.37% |
584,228
-17,600
| -3% | -$535K |
|
|
5
Fortive
FTV
$18.6B
| $13.9M | 12.34% |
321,791
+472
| +0.1% | +$21.8K |
|
|
6
Enovis
ENOV
$1.54B
| $5.16M | 4.58% |
103,298
-11,504
| -10% | -$543K |
|
7
Lineage Cell Therapeutics
LCTX
$274M
| $3.71M | 3.29% |
3,794,045
-325,755
| -8% | -$337K |
|
8
Winmark
WINA
$1.37B
| $3.42M | 3.03% |
19,390
-688
| -3% | -$116K |
|
|
9
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $2.8M | 2.49% |
+46,000
| New | +$2.8M |
|
10
Kinder Morgan
KMI
$72.5B
| $2.43M | 2.16% |
117,878
-2,953
| -2% | -$60.6K |
|
11
Inovio Pharmaceuticals
INO
$89.7M
| $1.28M | 1.13% |
51,858
-2,209
| -4% | -$67.2K |
|
12
Compugen
CGEN
$221M
| $1.26M | 1.12% |
297,333
-9,400
| -3% | -$35.2K |
|
|
13
Apple
AAPL
$4.8T
| $524K | 0.46% |
9,420
+60
| +0.6% | +$3.14K |
|
14
Amazon
AMZN
$2.69T
| $424K | 0.38% |
4,880
-300
| -6% | -$27.8K |
|
15
Serina Therapeutics
SER
$32.7M
| $407K | 0.36% |
5,832
-1,642
| -22% | -$156K |
|
16
Cisco
CSCO
$436B
| $215K | 0.19% |
4,349
-373
| -8% | -$19.4K |
|
|
17
Microsoft
MSFT
$2.99T
| $211K | 0.19% |
+1,520
| New | +$209K |
|
|
FIT
18
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $76K | 0.07% |
20,000
| – | – |
|
Similar funds
PC
AWA
AC
EWM
ICP
ACM
GE
BBWA
Defender Capital's Q3 2019 Portfolio in Review
As of Q3 2019, Defender Capital held 18 positions worth $113M, down 8.8% from $124M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Defender Capital's Q3 2019 filing shows 2 new, 2 increased and 13 reduced positions. Its largest new stake was Vanguard Short-Term Treasury ETF: 46,000 shares worth $2.8M. The largest sale was Berkshire Hathaway Class B, an estimated $2.24M.
By sector, the portfolio is most concentrated in Healthcare at 42% of assets, down from 43% a quarter earlier, followed by Financials and Consumer Staples.
- Defender Capital's largest Q3 2019 buy was Vanguard Short-Term Treasury ETF: 46,000 shares worth $2.8M.
- Defender Capital added most to Fortive in Q3 2019, an estimated $21.8K increase.
- Defender Capital's biggest Q3 2019 reduction was Berkshire Hathaway Class B, cutting an estimated $2.24M.
- Defender Capital's ten largest holdings make up 96% of its $113M portfolio in Q3 2019.
- Defender Capital opened 2 new positions and closed 0 in Q3 2019.
- Defender Capital's portfolio value fell 8.8% quarter-over-quarter to $113M.
Based on Defender Capital's 13F filing for Q3 2019, filed 17 Oct 2019.